105 related articles for article (PubMed ID: 19915373)
1. [Comprehensive analysis of gene abnormalities in acute myeloid leukemia according to the WHO classification].
Ishikawa Y
Rinsho Ketsueki; 2009 Aug; 50(8):597-603. PubMed ID: 19915373
[No Abstract] [Full Text] [Related]
2. [Acute myeloid leukemia].
Watanabe R
Rinsho Ketsueki; 2009 Mar; 50(3):154-9. PubMed ID: 19352081
[No Abstract] [Full Text] [Related]
3. Comprehensive analysis of cooperative gene mutations between class I and class II in de novo acute myeloid leukemia.
Ishikawa Y; Kiyoi H; Tsujimura A; Miyawaki S; Miyazaki Y; Kuriyama K; Tomonaga M; Naoe T
Eur J Haematol; 2009 Aug; 83(2):90-8. PubMed ID: 19309322
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and prognosis in acute myeloid leukemia--the art of distinction.
Löwenberg B
N Engl J Med; 2008 May; 358(18):1960-2. PubMed ID: 18450608
[No Abstract] [Full Text] [Related]
5. Prognostic factors in AML in relation to (ab)normal karyotype.
Stone RM
Best Pract Res Clin Haematol; 2009 Dec; 22(4):523-8. PubMed ID: 19959103
[TBL] [Abstract][Full Text] [Related]
6. Prospective study of 174 de novo acute myelogenous leukemias according to the WHO classification: subtypes, cytogenetic features and FLT3 mutations.
Bao L; Wang X; Ryder J; Ji M; Chen Y; Chen H; Sun H; Yang Y; Du X; Kerzic P; Gross SA; Yao L; Lv L; Fu H; Lin G; Irons RD
Eur J Haematol; 2006 Jul; 77(1):35-45. PubMed ID: 16573742
[TBL] [Abstract][Full Text] [Related]
7. [Prognostic factors of acute myeloid leukemia].
Inokuchi K
Nihon Rinsho; 2012 Apr; 70 Suppl 2():389-93. PubMed ID: 23133988
[No Abstract] [Full Text] [Related]
8. Molecular characterization of acute myeloid leukemia.
Döhner K; Döhner H
Haematologica; 2008 Jul; 93(7):976-82. PubMed ID: 18591623
[No Abstract] [Full Text] [Related]
9. KIT and FLT3 receptor tyrosine kinase mutations in acute myeloid leukemia with favorable cytogenetics: two novel mutations and selective occurrence in leukemia subtypes and age groups.
Sritana N; Auewarakul CU
Exp Mol Pathol; 2008 Dec; 85(3):227-31. PubMed ID: 18977345
[TBL] [Abstract][Full Text] [Related]
10. Molecular genetics of adult acute myeloid leukemia: prognostic and therapeutic implications.
Marcucci G; Haferlach T; Döhner H
J Clin Oncol; 2011 Feb; 29(5):475-86. PubMed ID: 21220609
[TBL] [Abstract][Full Text] [Related]
11. A rapid, one step assay for simultaneous detection of FLT3/ITD and NPM1 mutations in AML with normal cytogenetics.
Huang Q; Chen W; Gaal KK; Slovak ML; Stein A; Weiss LM
Br J Haematol; 2008 Jul; 142(3):489-92. PubMed ID: 18477048
[No Abstract] [Full Text] [Related]
12. [Detection of CCAAT/enhancer binding protein alpha gene mutations in acute myeloid leukemia].
Zhao JM; Wang HW; Xu ZF; Zhu L; Bai B; Ge XY
Zhonghua Xue Ye Xue Za Zhi; 2005 May; 26(5):299-302. PubMed ID: 15949295
[TBL] [Abstract][Full Text] [Related]
13. Risk assessment in patients with acute myeloid leukemia and a normal karyotype.
Bienz M; Ludwig M; Leibundgut EO; Mueller BU; Ratschiller D; Solenthaler M; Fey MF; Pabst T
Clin Cancer Res; 2005 Feb; 11(4):1416-24. PubMed ID: 15746041
[TBL] [Abstract][Full Text] [Related]
14. Characterization of acute myeloid leukemia with PTPN11 mutation: the mutation is closely associated with NPM1 mutation but inversely related to FLT3/ITD.
Hou HA; Chou WC; Lin LI; Chen CY; Tang JL; Tseng MH; Huang CF; Chiou RJ; Lee FY; Liu MC; Tien HF
Leukemia; 2008 May; 22(5):1075-8. PubMed ID: 17972951
[No Abstract] [Full Text] [Related]
15. [Detection of point mutation at second tyrosine kinase domain of FLT3 gene in acute myeloid leukemia].
Wang LH; Wang M; Zhou CL; Chen S; Zhang XW; Xing HY; Wang JX
Zhonghua Xue Ye Xue Za Zhi; 2005 Jun; 26(6):335-8. PubMed ID: 16185475
[TBL] [Abstract][Full Text] [Related]
16. Comparing apples and oranges in normal karyotype acute myeloid leukemia.
Medeiros BC
J Clin Oncol; 2009 Jan; 27(3):474; author reply 474-6. PubMed ID: 19075259
[No Abstract] [Full Text] [Related]
17. Mutual exclusion of ASXL1 and NPM1 mutations in a series of acute myeloid leukemias.
Carbuccia N; Trouplin V; Gelsi-Boyer V; Murati A; Rocquain J; Adélaïde J; Olschwang S; Xerri L; Vey N; Chaffanet M; Birnbaum D; Mozziconacci MJ
Leukemia; 2010 Feb; 24(2):469-73. PubMed ID: 19865112
[No Abstract] [Full Text] [Related]
18. Mutations of CEBPA in acute myeloid leukemia FAB types M1 and M2.
Snaddon J; Smith ML; Neat M; Cambal-Parrales M; Dixon-McIver A; Arch R; Amess JA; Rohatiner AZ; Lister TA; Fitzgibbon J
Genes Chromosomes Cancer; 2003 May; 37(1):72-8. PubMed ID: 12661007
[TBL] [Abstract][Full Text] [Related]
19. Classification of CEBPA mutated acute myeloid leukemia by GATA2 mutations.
Marceau-Renaut A; Guihard S; Castaigne S; Dombret H; Preudhomme C; Cheok M
Am J Hematol; 2015 May; 90(5):E93-4. PubMed ID: 25611491
[No Abstract] [Full Text] [Related]
20. Adult acute leukemia.
Cornell RF; Palmer J
Dis Mon; 2012 Apr; 58(4):219-38. PubMed ID: 22449370
[No Abstract] [Full Text] [Related]
[Next] [New Search]